Science News

Dual T1/T2 Nanoscale Coordination Polymers as Novel Contrast Agents for MRI: a Preclinical Study for Brain Tumor.

A new interesting article has been published in ACS Appl Mater Interfaces. 2018 Oct 23. doi: 10.1021/acsami.8b15594. [Epub ahead of print] and titled:

Dual T1/T2 Nanoscale Coordination Polymers as Novel Contrast Agents for MRI: a Preclinical Study for Brain Tumor.

Authors of this article are:

Suarez-Garcia S, Arias-Ramos N, Frias Botella C, Candiota AP, Arús C, Lorenzo J, Ruiz-Molina D, Novio F.

A summary of the article is shown below:

In the last years, extensive attention has been paid on designing and developing functional imaging contrast agents for providing accurate non-invasive evaluation of pathology in vivo. However, the issue of false-positives or ambiguous imaging and the lack of a robust strategy for simultaneous dual-mode imaging remain to be fully addressed. One effective strategy for improving it is to rationally design magnetic resonance imaging (MRI) contrast agents (CAs) with intrinsic T1/T2 dual-mode imaging features. In this work, the development and characterization of one-pot synthesized nanostructured coordination polymers (NCPs) which exhibit dual mode T1/T2 MRI contrast behaviour is described. The resulting material comprises the combination of different paramagnetic ions (Fe3+, Gd3+, Mn2+) with selected organic ligands able to induce the polymerization process and nanostructure stabilization. Among them, the Fe-based NCPs showed the best features in terms of colloidal stability, low toxicity, and dual T1/T2 MRI contrast performance overcoming the main drawbacks of reported CAs. The dual-mode CA capability was evaluated by different means: in vitro phantoms, ex vivo and in vivo MRI, using a preclinical model of murine glioblastoma. Interestingly, the in vivo MRI of Fe-NCPs show T1 and T2 high contrast potential, allowing simultaneous recording of positive and negative contrast images in a very short period of time while being safer for the mouse. Moreover, the biodistribution assays reveals the persistence of the nanoparticles in the tumor and subsequent gradual clearance denoting their biodegradability. After a comparative study with commercial CAs, the results suggest these nanoplatforms as promising candidates for the development of dual-mode MRI CAs with clear advantages.

Check out the article’s website on Pubmed for more information:

This article is a good source of information and a good way to become familiar with topics such as:



Categories: Science News